While panel sequencing is more rapid, WGS and WES allow for revisiting the genetic data upon identification of novel cardiomyopathy-associated genes from a once-off effort (e.g., the recent identification of disease-causing filamin C [FLNC]) but at an increased expense, computational time, bioinformatics, and computational requirement [34]. This evidence concerns the gene FLNC and cardiomyopathy.